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Around 1% of UK children have Autism Spectrum Disorder (ASD), a condition that 
fundamentally affects their ability to understand other people1. Children with autism 
struggle to communicate with others, can have difficulty with change, and may be 
overwhelmed by new sights and sounds. Many adults with ASD experience a 
reduced quality of life2. Financial costs are also high: supporting an individual with 
ASD across their lifespan is estimated to cost £1.5 million for those with intellectual 
disability, and almost £1 million for those without an intellectual disability3. In this 
article we will argue that the time is right for a significant increase in investment in 
early intervention for children with ASD and other neurodevelopmental disorders. 
Using ASD as an example, we will illustrate how recent research identifies 
revolutionary new avenues for developing and targeting interventions in early 
development.  We will also highlight how this is applicable beyond ASD by 
discussing the example of another common childhood-onset disorder, Attention 
Deficit Hyperactivity Disorder (ADHD). We suggest that new approaches may 
transform current debates on the ethics of early screening and early intervention. 
Finally, we consider how such approaches may narrow the gap between research 
and practice. Taken together, we believe that we are poised to make 
transformational changes in detection and treatment for early emerging 
neurodevelopmental disorders.    
 
Early intervention and early identification 
Early intervention offers the greatest potential for optimal outcomes for 
children with ASD.  In a groundbreaking study, Pickles and colleagues studied 
language development in 192 children with autism followed longitudinally from age 
two to age 194. Between age two and six years, there was substantial variability in 
language trajectories. Some children made substantial gains and ended with 
language in the typical range, whilst others remained significantly delayed. After age 
six, trajectories remained remarkably stable such that children with poor language 
skills at the age of 6 still had poor language skills 13 years later.  This data indicates 
that the effects of a supportive environment may be maximal in the first years of life, 
providing a powerful illustration of early neurodevelopmental plasticity. 
Randomized controlled trials have indeed shown significant benefits of early 
intervention for toddlers with ASD5–7. The success of such interventions is greater 
when started at a younger age8. Early intervention is economically beneficial: a 
recent Dutch study estimated the potential lifetime savings as 1.1 million euros per 
person9. However, current intervention models are intensive (often 20 to 40 hours per 
week), placing a significant burden on individuals and families. A further major 
challenge is that access to existing interventions typically requires early diagnosis 
(see Box 1). Jeremy Parr and colleagues recently investigated the experienced age 
of diagnosis for 2,134 families in the ASD-UK national database.  Strikingly, this work 
showed that the average age of diagnosis in the UK has remained stable at 55 
months for the last decade.  Even within children diagnosed under age 3, the 
average age of diagnosis was 30 months. Since parents first show concerns at 10 to 
16 months10, this diagnostic gap is a substantial challenge to the provision of early 
intervention for children with emerging ASD. 
We propose that there is a common solution to the twin challenges of 
developing better early identification and intervention approaches. Traditional 
approaches to mental health focus on identifying and targeting the surface symptoms 
that are used in diagnostic classification systems. Diagnosis is often required before 
treatment can commence, because the ‘disorder’ has to be identified in order to 
provide relevant treatments. We contend that we require a revolution in this approach 
to mental health conditions.  Instead of focusing on surface features of the condition, 
we should be targeting the neurodevelopmental mechanisms that produce troubling 
symptoms in early development11.  This approach is comparable to the prescription 
of statins for those at risk of heart disease (NICE, 2014a), a drastic change in the 
management of this condition. Such a mechanistic approach would allow infants at 
heightened risk for particular symptom clusters to be identified prior to emergence of 
a recognizable clinical syndrome. Intervention could be provided based on the 
presence of the mechanism, and need not wait for clinical diagnosis. This would 
significantly reduce the troubling delays experienced by children in accessing 
intervention services.  Early mechanistic interventions may in the long-term 
ameliorate or even prevent the emergence of troubling symptoms (e.g. lack of 
language), whilst leaving potential strengths (such as creativity or memory) 
untouched.  Finally, mechanistic approaches are not limited to particular diagnostic 
categories and may more faithfully ‘carve nature at its joints’. For example, in the 
latter part of the article, we discuss how attention difficulties may be relevant to both 
ASD and ADHD risk in early development12. These revolutionary changes will be 
made possible through a radical new approach to the study of neurodevelopmental 
disorders: prospective longitudinal studies of infants at heightened risk.  
 
Developmental paths to autism: Baby sibs studies 
In 2005, Dr. Lonnie Zwaigenbaum and colleagues published a seminal study of 
infants with older siblings with ASD13.  Because ASD runs in families, about 20% of 
such infants are diagnosed with autism by their third birthday14. For the first time, 
researchers could study the emergence of ASD in real time. Dr Zwaigenbaum’s team 
showed that babies diagnosed with ASD at 24 months showed subtle developmental 
problems by 12 months of age. These included unusual eye contact, poor imitation, 
poor visual tracking, lack of smiling and laughter, and being slow to shift attention 
between two toys. This groundbreaking study has inspired more than a decade of 
‘baby sib’ research that in turn has revolutionalised our understanding of the earliest 
signs and symptoms of autism.   
Baby sibs research has shown that by the second year of life, clear 
behavioural warning signs emerge in infants with later autism. These include failure 
to respond to name, poor eye contact and slowed language development. Any loss 
of skills such as walking or talking is of substantial concern. These ‘red flags’ are now 
widely publicized by charities and other organisations (Box 2).  But what mechanisms 
underlie these early symptoms? In infants under 12 months, there are few clear 
behavioural signs of autism that could be used to identify individual children at risk.  
However, there are subtle differences between groups of infants with later autism 
and those who develop typically. For example, at 6 months infants with later autism 
often struggle to hold their head steady when pulled to sit15, and other early motor 
delays have been observed when large groups are studied16.  Brain growth may also 
be subtly different, with faster expansion of head circumference and brain size in the 
first year17.  These changes suggest that broad changes in brain development 
precede the emergence of specific autism symptoms.  
Contrary to expectations, researchers have identified very few changes in 
overt social behavior in young infants with later autism.  For example, infants with 
later autism look at people just as much as typically developing infants in the first 
year of life18.  However, developmental trajectories may be critical in detecting 
changes that are not apparent at a single time-point. For example, infant boys with 
later autism show declining patterns of gaze to eyes between 2 and 6 months that 
can be detected with eye-tracking technology19.   There may also be differences in 
how the infant’s brain is responding to the incoming social information. Using EEG 
(Box 3), Mayada Elsabbagh and colleagues showed that 6-month-old infants with 
later ASD show a reduced ability to detect changes in eye gaze direction 20. Neural 
responses to faces are also slower and less prolonged in 6-month-old infants with 
later ASD21, suggesting reduced engagement of attention to social stimuli.  As a 
group, infants at heightened risk for ASD also show markedly reduced social brain 
activity in response to social videos22.  Taken together, these results suggest an 
alteration of social brain specialization in the early development of infants with ASD. 
 
Implications for early intervention 
The infant brain becomes socially specialized through a complex interaction 
between innate programming and experience of the early environment23.  If early 
social brain development is altered in ASD, interventions that support the early social 
environment may be powerful.  In 2015, Green and colleagues reported the results of 
the first randomized controlled trial of a parent-mediated intervention for infants with 
older siblings with ASD. The 12-week intervention helped to enrich the child’s social 
environment by teaching parents to boost their responsivity to their infant’s bids for 
attention. Results showed that at 14 months, infants who received the treatment 
tended to show increased attentiveness to their parent.  Promising effects were 
found on other potential early markers for later ASD, such as better attention shifting 
between two objects on a screen. An independent study using a similar intervention 
approach identified significant improvements in neurocognitive markers of social 
attention (Jones et al. in review). The small size of both studies means that further 
work is needed, but these results are highly promising in suggesting that relatively 
low-cost interventions could be used to target the mechanisms that underpin 
symptom emergence in infants with ASD.  
 
Moving beyond autism 
Mechanistic approaches to early intervention may not be restricted to 
particular diagnostically-defined disorders. For example, a wide range of infants can 
show early social communication vulnerabilities and thus may benefit from early 
intervention that could support their development. In a large study of typically 
developing infants, parents with higher levels of social anxiety had infants who 
showed poorer social attention on a range of neurocognitive measures similar to 
those used with infants at risk for ASD21.  Long-term follow-up will indicate whether 
these infants (who are currently developing typically) are more vulnerable to shyness 
or social anxiety in later development, and whether they may benefit from brief 
parent-mediated interventions designed to support their social engagement. Such 
low-cost interventions may have broad positive impacts for children across the 
spectrum of social difficulties. 
Attention is another critical neurocognitive domain in infancy. Attention 
difficulties are common in children with ASD, but are also a diagnostic feature of 
Attention Deficit Hyperactivity Disorder (ADHD).  Attention difficulties in the two 
conditions may share developmental roots. First, the two conditions have substantial 
overlap in genetic risk factors24. Second, ASD and ADHD commonly co-occur within 
individuals and their families24,25.  Third, patterns of performance on many 
neurocognitive tasks are similar in the two conditions26. Fourth, poor attention skills in 
infancy (such as difficulty sustaining attention) are apparent prior to both ASD and 
ADHD diagnosis27,28. Early alterations in attention may thus be a common treatment 
target for infants at risk of ASD and ADHD. To test this hypothesis, we are currently 
conducting the first large longitudinal study of infants with older siblings with ASD 
and/or ADHD. Within this study (see Box 3) we will examine attention and other 
domains in very early development to identify distinct and similar causal paths.  
We are currently testing new interventions previously demonstrated to 
improve attention in low-risk young infants. In 2011, Wass and colleagues reported 
that attentional control (the ability to move attention at will) can be improved in 
typically developing infants by playing a series of innovative gaze-contingent games 
over a short period29.  In these games, infants watch objects on a screen and can 
control them by moving their gaze. This can now be achieved with relatively low-cost 
eye-tracking systems that use infrared light to detect where an infant is looking on 
the screen.   We are currently using these games with infants at high familial risk for 
ADHD to test whether helping infants to improve their attentional control skills 
provides significant benefits for learning and development (www.interstaars.org). In 
an exciting new collaboration, we are also working with Zwaigenbaum and 
colleagues at the University of Alberta to test whether this intervention is also 
beneficial for infants at risk for ASD. This approach will allow us to test the 
hypothesis that such potentially low-cost interventions could be applicable to a range 
of risk groups. 
 
Ethics of early intervention 
Although early detection and intervention can be effective, concerns remain about 
widespread implementation of screening and treatment programs (Box 1).  
Overdiagnosis is a concern, particularly for ADHD where reports indicate far higher 
rates of diagnosis and prescription amongst children who are young for their school 
year.  Children who are relatively young for their school year may be judged to have 
difficulty30 with attention and concentration skills because of their relative immaturity 
in comparison to their peers, not because they have a neurodevelopmental disorder.  
Developing more objective tools that do not rely on subjective comparisons made by 
teachers or parents may be one way to tackle this issue. 
 The autism and ADHD communities also stress the need to consider whether 
intervention is desirable. The ‘neurodiversity’ movement argues that 
neurodevelopmental ‘disorders’ like ASD and ADHD should instead be seen as being 
on the spectrum of individual differences; applying a disease model to these 
conditions is inappropriate.  The neurodiversity movement is sometimes 
misrepresented as being against any form of treatment – rather, the goal is generally 
to move away from ‘curing’ and towards options that might enable individuals with 
ASD or ADHD to reach their full potential  (e.g. 
http://www.psychologytoday.com/blog/my-life-aspergers/201310/what-is-
neurodiversity).  Not all individuals with ASD or ADHD will want to access treatment 
or intervention options, since not all individuals will feel that they have difficulties with 
which they need help. However, the needs of those individuals (particularly with 
ASD) who cannot communicate and thus cannot contribute to debates in this area 
must also be considered. Many individuals with ASD or ADHD have significant 
strengths, like artistic ability, creativity, detail-orientation or skill with computers.  We 
must ensure that intervention techniques support improved quality of life but do not 
diminish these skills. If mechanisms that produce challenging symptoms can be 
disentangled from those that produce strengths, we may be able to develop more 
targeted treatment options.   
This question is particularly problematic when applied to intervention in the early 
years, because infants and young children cannot themselves choose whether to 
receive it.  Led by Sue-Fletcher Watson at the University of Edinburgh, we recently 
asked 2,317 stakeholders across Europe about their views on early autism 
research31. Respondents included parents of children with autism, clinicians working 
with families with autism, and autistic adults. Whilst respondents were generally very 
positive about early autism research, adults with autism were less likely to want to 
prioritise research on early diagnosis than other groups. However, adults with autism 
were significantly more likely to prioritise intervention designs.  We need 
interventions targeted to the mechanisms that produce unwelcome symptoms, rather 
than efforts to diagnose and treat the full syndrome at younger ages. Moving forward, 
it is critical to engage adults with autism and their family members in the research 
design process to ensure that all views are represented when designing intervention 
studies. However, ensuring that the views of individuals with more significant 
communication problems are recognized remains a significant challenge.  
 
Mind the Gap 
Translation of new research findings to improvements for service users remains a 
significant issue across child psychiatry.  Research on early autism and ADHD is in 
its infancy, and substantial progress is required before some of the newest findings 
can be translated into practice.  For example, many ‘biomarkers’ for ASD actually 
represent group differences, and are not individually predictive.  Although this is a 
challenge, predicting ASD as a diagnostic category with high accuracy is not the 
goal. Rather, identifying markers of symptoms of ASD that may be particularly 
problematic (such as social communication problems, or sensory sensitivities) is 
critical. Further, markers for screening are usually judged by their sensitivity (what 
percentage of children with the disorder are identified?) and their positive predictive 
value (of the children with the marker, what proportion are later diagnosed with the 
condition?). However, markers for mechanisms that may be sensitive to intervention 
may actually have a poor positive predictive value to later diagnosis, because the 
child’s environment between assessment of the marker and eventual diagnosis 
would be expected to have a relatively greater effect. Such considerations are 
important and under-discussed in the field.  
Reproducibility and generalizability are also critical challenges.  There have 
been very few replication studies of neurocognitive markers of later ASD to date. 
Such efforts are underway – with a team of investigators we are currently running a 
multi-site study of infants with older siblings with ASD across Europe 
(www.eurosibs.eu).  This study will attempt to replicate several key findings from the 
baby sib literature. Generalizability is also very important.  For example, we recently 
showed that some early ‘markers’ for later ASD may only be related to later autism 
symptoms in boys and not girls32. In addition, findings from baby sibs research will 
need to be replicated in other populations. We are currently running such studies 
with infants with known genetic conditions linked to ASD and ADHD, such as 
tuberous sclerosis; other work should identify infants with early behavioral signs and 
examine whether neurocognitive markers could enhance individual prediction. 
Despite the challenges, new mechanistic interventions hold significant 
translational potential. Parent-mediated interventions that appear efficacious in baby 
sibs33 are based on existing programs that are low-cost, manualised and have been 
used in other populations in the community. Once sufficient evidence of their efficacy 
in the short and long-term accumulates, roll-out would be more straightforward. Other 
new interventions such as gaze-controlled eyetracking programs rely on equipment 
that is becoming significantly cheaper. In the medium-term, such training 
programmes could be operated remotely by parents, with less need for clinician 
input. Such advances improve the potential accessibility of interventions, and lower 
the bar in terms of the cost-benefit ratio of intervention provision.   
 
Summary 
Prospective longitudinal studies of infants at heightened risk of neurodevelopmental 
disorders provide the potential for developing new interventions that are targeted at 
the mechanisms that underlie symptom emergence. There is much work to do in 
improving the quality and replicability of early indicators, and testing new intervention 
approaches in rigorously controlled trials. However, this new mechanistic approach 
has significant potential to overcome some of the ethical and translational obstacles 
to the provision of early intervention to vulnerable children. As such, these advances 
could transform the outlook for infants at heightened risk for conditions like ASD and 
ADHD. The resources that need to be devoted to these efforts are not trivial, but the 
potential economic, societal and personal benefits vastly outweigh the possible 
costs. 
-  
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Box 1: Should we screen for autism? 
In 2007, the American Academy of Pediatrics recommended continuous 
developmental surveillance and specific autism screening and 18 months, 24 
months, and whenever a parent or provider expresses concern. These guidelines 
were based on the growing understanding of early red flags for the condition (see 
Box 1).  Recent reports suggest that this recommendation has significantly reduced 
age of diagnosis in the US^. However, in February 2016 the US Preventative 
Services Task Force decided not to recommend universal screening in the US on the 
basis that there is insufficient evidence of benefit. The Task Force accepted that 
common screening tools (like the Modified Checklist for Autism in Toddlers 
questionnaire) were effective.  Further, there is evidence that early intervention can 
produce significant gains for young children. However, this work on early intervention 
has been conducted with clinically-referred rather than screen-positive populations. 
The Task Force thus called for more research following children from screening to 
diagnosis and treatment.  This judgment echoes the findings of the UK National 
Screening Committee, who in 2012 concluded that there was no justification for 
universal screening for ASD.  The UK panel also argued that there was a need for 
greater information about the long-term benefits of early intervention before the value 
of screening could be determined. Whilst the need for more research is widely 
accepted by the field, many prominent clinicians and researchers disagree with the 
Task Force’s approach. Autism Speaks and other prominent charities have argued 
that the risk to benefit ratio ‘strongly favours universal screening for autism’*.  The 
debate on screening for autism requires full consideration of the scientific, ethical, 
economic and societal dimensions, and the urgent need for further research is clear. 
 
* https://www.autismspeaks.org/blog/2016/02/17/keeping-
%E2%80%9Cgrade-a%E2%80%9D-universal-early-screening-autism 
 
^ https://www.sciencedaily.com/releases/2016/04/160430100542.htm 
 
 
Box 2: Red Flags and other internet resources  
 
There are a variety of excellent resources for finding out more about early signs of 
ASD and ADHD, and support and treatment options in the UK.   
 
 Autism Speaks (a US charity) offers a range of videos that illustrate atypical 
and typical development in domains related to ASD: 
http://www.autismspeaks.org/what-autism/video-glossary 
 The US Center for Disease Control also offers a range of information about 
early red flags for ASD: http://www.cdc.gov/ncbddd/autism/signs.html 
 Research Autism is a UK charity devoted to summarising research on autism 
for families. In particular, they provide excellent information on the evidence-
base for a range of treatment options: http://www.researchautism.net/ 
 The National Autistic Society and Autistica are UK charities that provides a 
range of information and resources for families affected by ASD: 
http://www.autism.org.uk/; http://www.autistica.org.uk/ 
 NHS choices provides some information on signs of ADHD, although 
descriptions are mainly applicable to older children: 
http://www.nhs.uk/Conditions/Attention-deficit-hyperactivity-
disorder/Pages/Symptoms.aspx 
 ADDISS, UK ADHD and the ADHD Foundation are UK charities who provide 
a range of information about ADHD: http://www.addiss.co.uk/; 
http://www.adhdfoundation.org.uk/parent.php; 
http://www.ukadhd.com/index.htm. 
 
 
 
 
Box 3: New studies of early ASD and ADHD 
In the UK, the BASIS study (British Autism Study of Infant Siblings) is a UK-
wide network dedicated to the study of infants with older siblings with ASD.  The 
BASIS team, led by Professor Mark Johnson at Birkbeck College London and 
Professor Tony Charman at Kings College London have recently launched STAARS 
(Study of Attention and ADHD Risk in Siblings), which will follow both infants with 
older siblings with ASD and infants with older siblings with ADHD in the same 
protocol.  Infants are studied at 5, 10, 14, 24 and 36 months.  Methods used include 
eyetracking (A), electroencephalography (EEG; B) and Near InfraRed Spectroscopy 
(NIRS; C), both noninvasive measures of brain activity (see pictures); eye-tracking, a 
way of studying what infants attend to; and measures of behavior, cognition and 
arousal. Following both groups of infants in the same protocol will allow us to 
compare and contrast the early developmental paths to the two disorders.  We will be 
able to ask whether there may be similar or different early markers for ASD and 
ADHD, and whether there may be core paths that could be targeted by prodromal 
interventions. Further information can be found on our website: www.staars.org. 
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